PHGDH and lymphoma: This interaction between extracellular serine and PHGDH inhibition may open up new therapeutic opportunities, either in terms of combining pharmacological inhibition of PHGDH with a serine/glycine-free diet or in treating lymphoma in serine/glycine-depleted environments such as the CNS (36).